corporate_fare

Central Finland Hospital District Central Finland Hospital Nova

Address
Hoitajantie 3

Sponsor Overview

assignment
1
sponsored trial
science
4
molecules
location_city
4
research centres
public
1
country
person_search
4
investigators

Specializations

Prostate cancer

Clinical research activity is centered on prostate cancer, with interest in treatment-related quality of life and supportive care during androgen deprivation therapy and radiation therapy.

  • Sexual dysfunction
  • Hormone therapy adverse effects
  • Radiation therapy–associated supportive care

The sponsor’s trial portfolio reflects a focus on managing functional and symptom-related outcomes in men receiving treatment for prostate cancer.

Endocrine and hormonal effects

Research interest includes the hormonal consequences of androgen deprivation therapy, with attention to restoring balance in patients experiencing treatment-related changes in sexual function and overall well-being.

  • Estrogen-based supportive treatment
  • Hormone-related symptom management
  • Treatment-induced quality-of-life changes

These topics place emphasis on the endocrine dimension of care in men undergoing therapy for prostate cancer.

Exercise and rehabilitation

The sponsor also funds work related to exercise as a supportive intervention for patients coping with the adverse effects of cancer treatment, particularly during prolonged hormonal suppression.

  • Physical activity support
  • Rehabilitation in oncology
  • Functional recovery

This area links movement-based care with symptom relief and maintenance of daily functioning during prostate cancer treatment.

Men’s health and supportive oncology

Clinical interest extends to men’s health concerns arising during cancer treatment, especially symptoms affecting intimacy, physical comfort, and treatment tolerance.

  • Supportive oncology
  • Patient-reported outcomes
  • Symptom burden during cancer care

Research in this area is directed toward the lived experience of patients receiving active treatment for prostate cancer.

Sponsored Trials

Data & Insights

science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 4 total (0% not shared with other sponsors)

This sponsor works with 4 molecules, of which 0 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 4 sites collaborated multiple times

This sponsor has worked with 4 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Male Urogenital Diseases1 trial
    111 other sponsors

Partnered Research Centres

4 centres
location_city
assignment16
Central Finland Hospital District Central Finland Hospital Nova
Address
Hoitajantie 3, 40620 Jyväskylä
Learn morearrow_forward
location_city
assignment40
Tampere University Hospital
Address
Teiskontie 35, 33520 Tampere
Learn morearrow_forward
location_city
assignment1
University Of Jyvaskyla
Address
Survontie 9, 40500 Jyväskylä
Learn morearrow_forward
location_city
assignment37
Varsinais-Suomen hyvinvointialue
Address
Kiinamyllynkatu 4-8, 20520 Turku
Learn morearrow_forward

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Central Finland Hospital District Central Finland Hospital Nova.

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.